Potential Association between Vaginal Microbiota and Cervical Carcinogenesis in Korean Women: A Cohort StudyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers examined whether vaginal microbiota composition tracks with cervical carcinogenesis in Korean women. They compared healthy controls to patients with cervical intraepithelial neoplasia (CIN 2/3) and invasive cervical cancer.
How was it studied?
The cohort included 23 women: 7 healthy controls, 8 with CIN, and 8 with invasive cervical cancer. Vaginal bacterial communities were characterized using amplicon sequencing on the Ion Torrent PGM platform.
What did they find?
CIN and cancer patients showed vaginal dysbiosis compared to healthy controls, with alpha diversity trending higher along disease progression. Lactobacillus and Gardnerella differed most between healthy controls and CIN, while Streptococcus was differentially abundant in cancer versus CIN. The three genera together gave strong diagnostic performance, with area-under-curve values of 0.982, 0.953, and 0.922.
Why it matters
The findings suggest Gardnerella and Streptococcus abundance may be involved in cervical cancer advancement, and point to vaginal microbiota as a potential biomarker panel for monitoring cervical carcinogenesis alongside existing bacterial vaginosis markers.